Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Comparison of 13 acellular pertussis vaccines: adverse reactions.

Decker MD, Edwards KM, Steinhoff MC, Rennels MB, Pichichero ME, Englund JA, Anderson EL, Deloria MA, Reed GF.

Pediatrics. 1995 Sep;96(3 Pt 2):557-66.

PMID:
7659476
2.

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.

Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD.

Pediatrics. 1997 Nov;100(5):772-88.

PMID:
9346976
3.

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children.

Pichichero ME, Edwards KM, Anderson EL, Rennels MB, Englund JA, Yerg DE, Blackwelder WC, Jansen DL, Meade BD.

Pediatrics. 2000 Jan;105(1):e11.

PMID:
10617748
4.

Effect of gender, race, and parental education on immunogenicity and reported reactogenicity of acellular and whole-cell pertussis vaccines.

Christy C, Pichichero ME, Reed GF, Decker MD, Anderson EL, Rennels MB, Englund JA, Edwards KM, Steinhoff MC.

Pediatrics. 1995 Sep;96(3 Pt 2):584-7.

PMID:
7659481
5.

Defining the key parameters for comparing reactions among acellular and whole-cell pertussis vaccines.

Pichichero ME, Christy C, Decker MD, Steinhoff MC, Edwards KM, Rennels MB, Anderson EL, Englund JA.

Pediatrics. 1995 Sep;96(3 Pt 2):588-92.

PMID:
7659482
6.

Comparison of 13 acellular pertussis vaccines: overview and serologic response.

Edwards KM, Meade BD, Decker MD, Reed GF, Rennels MB, Steinhoff MC, Anderson EL, Englund JA, Pichichero ME, Deloria MA.

Pediatrics. 1995 Sep;96(3 Pt 2):548-57.

PMID:
7659475
7.

A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccines.

Steinhoff MC, Reed GF, Decker MD, Edwards KM, Englund JA, Pichichero ME, Rennels MB, Anderson EL, Deloria MA, Meade BD.

Pediatrics. 1995 Sep;96(3 Pt 2):567-70.

PMID:
7659477
8.

Association of reactions after consecutive acellular or whole-cell pertussis vaccine immunizations.

Deloria MA, Blackwelder WC, Decker MD, Englund JA, Steinhoff MC, Pichichero ME, Rennels MB, Anderson EL, Edwards KM.

Pediatrics. 1995 Sep;96(3 Pt 2):592-4.

PMID:
7659483
9.

Comparison of the safety and immunogenicity of acellular (BIKEN) and whole-cell pertussis vaccines in 15- to 20-month-old children.

Marcinak JF, Ward M, Frank AL, Boyer KM, Froeschle JE, Hosbach PH 4th.

Am J Dis Child. 1993 Mar;147(3):290-4. Erratum in: Am J Dis Child 1993 Jun;147(6):626.

PMID:
8438810
10.

Randomized controlled trial of acellular diphtheria, pertussis and tetanus vaccines in southern Ghana.

Afari EA, Kamiya Y, Nkrumah FK, Dunyo SK, Akpedonu P, Kamiya H, Fukai F.

Ann Trop Paediatr. 1996 Mar;16(1):39-48.

PMID:
8787364
11.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group.

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
13.

A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine.

Stehr K, Cherry JD, Heininger U, Schmitt-Grohé S, uberall M, Laussucq S, Eckhardt T, Meyer M, Engelhardt R, Christenson P.

Pediatrics. 1998 Jan;101(1 Pt 1):1-11.

PMID:
9417143
14.

Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age.

Halperin SA, Scheifele D, Barreto L, Pim C, Guasparini R, Medd L, Meekison W, Eastwood BJ.

Pediatr Infect Dis J. 1999 Sep;18(9):772-9.

PMID:
10493336
15.

Immunogenicity of a five-component acellular pertussis vaccine in infants and young children.

Halperin SA, Barreto L, Friesen B, Meekison W.

Arch Pediatr Adolesc Med. 1994 May;148(5):495-502.

PMID:
7910089
16.

Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.

Bernstein HH, Rothstein EP, Reisinger KS, Blatter MM, Arbeter AM, Fontana ME, Jacobs JM, Long SS, Rathfon H, Crayne O, et al.

Pediatrics. 1994 Apr;93(4):656-9.

PMID:
8134224
17.

Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infants.

Shek LP, Khor ES, Tan GH, Low KT, Ong D, Roy J, Han HH, Bock HL, Lee BW.

Southeast Asian J Trop Med Public Health. 2003 Dec;34(4):863-8.

PMID:
15115101
18.

Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age.

Bernstein DI, Smith VE, Schiff GM, Rathfon HM, Boscia JA.

Pediatr Infect Dis J. 1993 Feb;12(2):131-5.

PMID:
8426770
19.

Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents.

Tran Minh NN, He Q, Ramalho A, Kaufhold A, Viljanen MK, Arvilommi H, Mertsola J.

Pediatrics. 1999 Dec;104(6):e70.

PMID:
10586004

Supplemental Content

Support Center